6:15am ET
Investing
The 5 Most Shorted NYSE Stocks: Chesapeake Bucks the Trend
The most shorted stock traded on the New York Stock Exchange — Chesapeake Energy — bucked the short interest trend with a modest gain in February.
PFE Coverage Page 63
12:45pm ET
Health and Healthcare
Pfizer Sinks Despite Winning FDA Approval
Pfizer has announced that the FDA approved Xeljanz XR (tofacitinib citrate) extended-release tablets for the once-daily treatment of moderate to severe rheumatoid arthritis in certain patients.
Chris Lange 9:50am ET
Investing
Top Hedge Funds Love These 5 Big Blue-Chip Dividend-Paying Stocks
These stocks make good sense for long-term patient investors that have a growth and income total return bias in their portfolios.
11:40am ET
Health and Healthcare
Big Dividend Pharmaceutical Stock Now Jefferies Top Global Sector Pick
In a new research report, Jefferies shuffles some of the pharmaceutical stocks in its coverage universe and a beaten-down dividend leader is now the top pick globally.
8:20am ET
Investing
4 Blue Chip Stocks With Dividends at Least 4% and Big Upside Potential
For worried investors that need an income stream, all these top stocks make good sense for growth and income portfolios.
8:55am ET
Health and Healthcare
Pfizer Settles Medicaid Case for $785 Million
Pfizer has announced that it had settled outstanding claims for a total of more than $784 million related to calculated Medicaid rebates for the drug Protonix.
Paul Ausick 9:32am ET
Health and Healthcare
6 Biotech and Pharma Stocks Analysts Want You to Buy Now
Here are six biotech and pharma stocks that analysts are telling their firm's clients to buy now for solid upside opportunities ahead.
9:15am ET
Health and Healthcare
Short Sellers Increase Bets in Major Pharma
The January 29 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest increased.
6:15am ET
Investing
The 6 Most Shorted NYSE Stocks: Short Sellers Pile on Alcoa, Freeport-McMoRan Again
Among the six most heavily shorted stocks traded on the New York Stock Exchange, short sellers continued to pile on Alcoa and Freeport-McMoRan between the January 15 and January 29 settlement dates.
11:35am ET
Health and Healthcare
Why Merrill Lynch Sees Big Upside in Pfizer (and Even More With Allergan)
Merrill Lynch has decided to add Pfizer as its new top pick for 2016. The firm reiterated a Buy rating with a $39 price target.
8:55am ET
Investing
Top Analyst Upgrades and Downgrades: Apple, Freeport-McMoRan, Kinross Gold, Pfizer, Plains All American, Salesforce, Tesla, Yelp and More
The top analyst upgrades, downgrades and initiations seen on Tuesday include Apple, Freeport-McMoRan, Kinross Gold, Pfizer, Plains All American, Salesforce,com, Tesla and Yelp.
8:25am ET
Health and Healthcare
4 Big Dividend Pharmaceutical Stocks to Buy That Are Very Cheap Now
If you ever want to look for value in a sector in the stock market, then when you see Congress calling in some of the top companies to scold them for political…
10:15am ET
Health and Healthcare
How Analysts View Pfizer and Merck After Earnings
After Pfizer and Merck released their most recent earnings reports last week, analysts weighed in on both of these pharmaceutical giants.
10:45am ET
Investing
Merrill Lynch Has 4 Very Oversold Blue Chip Dividend Stocks to Buy Now
Needless to say, the stock market can be a very cruel mistress. So what are patient long-term investors to do?
8:05am ET
Health and Healthcare
Investors OK With Pfizer Earnings, Not OK With Guidance
Pfizer reported better-than-expected fourth-quarter and full-year 2015 results before markets opened Tuesday morning.
Paul Ausick